Skip to main content
SpringerLink
Log in

Interleukin 12 and innate molecules for enhanced mucosal immunity

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Recent strategies for understanding the mechanisms underlying mucosal immune responses and subsequent development of mucosal vaccines for induction of targeted immunity now include cytokines and molecules of innate immunity. These studies have shown that cytokines influencing the development of T helper (Th) cells differentially affect the outcome of mucosal vs systemic immune responses to mucosal vaccines. Serum antigen-specific antibody (Ab) responses were enhanced when either IL-6 or IL-12 was mucosally administered with a protein antigen, while only IL-12 induced antigen-specific mucosal IgA Ab responses. Mucosal IL-6 and IL-12 also affected the type of Th cell responses induced by CD4+ T cells from mice that received IL-12 secreted larger amounts of IFN-γ and IL-6 when compared with mice nasally treated with IL-6. Discrepancies in the ability to enhance mucosal or systemic immune responses were also observed when human neutrophil peptide (HNP) defensins or lymphotactin were nasally coadministered with protein antigens. Only lymphotactin promoted mucosal secretory IgA (S-IgA) Ab responses while both lymphotactin and defensins enhanced systemic immunity to mucosally co-administered protein antigens. Mixed antigen-specific Th1-and Th2-type CD4+ T cell responses were induced in the systemic compartment by both lymphotactin and the mixture of HNP-1, HNP-2, and HNP-3 defensins. However, HNPs failed to significantly enhance cytokine secretion by mucosally derived, antigen-specific CD4+ T cells relative to those isolated from the systemic compartment. In summary, these studies clearly show that IL-12 and lymphotactin are able to trigger S-IgA Ab responses and provide new avenues for the design of safe and targeted mucosal vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N: Impaired mucosal immune response in interleukin 4-targeted mice. J Exp Med 1995;181:41–53.

    Article  PubMed  CAS  Google Scholar 

  2. Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Bluethmann H, Fujihashi K, Kiyono H, McGhee JR: Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. Immunol 1995;155:4621–4629.

    CAS  Google Scholar 

  3. Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, Roberts M, Bluethmann H, Hiroi T, Kiyono H, McGhee JR: Oral immunization of interleukin-4(IL-4) knockout mice with a recombinant Salmonella starin or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun 1996;64:1516–1525.

    PubMed  CAS  Google Scholar 

  4. Van Cott JL, Staats HF, Pascual DW, Roberts M, Chatfield SN, Yamamoto M, Coste M, Carter PB, Kiyono H, McGhee JR: Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 1996;156: 1504–1514.

    Google Scholar 

  5. Seder RA, Gazzinelli R, Sher A, Paul WE: Interleukin 12 acts directly on CD4+ cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sc (USA) 1993;90: l0188–10192.

    Article  Google Scholar 

  6. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–173.

    Article  PubMed  CAS  Google Scholar 

  7. Finkelman FD, Holmes J, Katona IM, Urban Jr. JF, Beckmann MP, Parks LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303–333.

    Article  PubMed  CAS  Google Scholar 

  8. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635–673.

    Article  PubMed  CAS  Google Scholar 

  9. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827–845.

    Article  PubMed  CAS  Google Scholar 

  10. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12])inducesThelper type 1 (Thl)-specific immune responses and inhibits the developmentof IL-4-producing Th cells. J Exp Med 1993;177:1199–1204.

    Article  PubMed  CAS  Google Scholar 

  11. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251–276.

    PubMed  CAS  Google Scholar 

  12. Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappacher G, Kock A, Micksche M, Malejczyk J, Schauer E: IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 1989;143:1206–1209.

    PubMed  CAS  Google Scholar 

  13. Bass HZ, Yamashita N, Clement LT: Heterogenous mechanisms of human cytotoxic T lymphocyte generation II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations. J Immunol 1993;151:2895–2903.

    PubMed  CAS  Google Scholar 

  14. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997;185:461–469.

    Article  PubMed  CAS  Google Scholar 

  15. Kishimoto T: Thebiology of interleukin-6. Blood 1989;74:1–10.

    PubMed  CAS  Google Scholar 

  16. Vogel LA, Showe LC, Lester TL, McNutt RM, VanCleave VH, Metzger DW: Direct binding of IL-12 to human and murine B lymphocytes. Intern Immunol 1996; 8:1955–1962.

    Article  CAS  Google Scholar 

  17. Metzger DW, McNutt RM, Collins JT, Buchanan JM, VanCleave VH, Dunnick WA: Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur JImmunol 1997; 27:1958–1965.

    Article  CAS  Google Scholar 

  18. Li L, Young D, Wolf SF, Choi YS: Interleukin-12 stimulates B cell growth by inducing IFN-gamma. Cell Immunol 1996;168:133–140.

    Article  PubMed  CAS  Google Scholar 

  19. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR: Interleukins and IgA synthesis. Human and murine interleukin-6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989;169:2133–2148.

    Article  PubMed  CAS  Google Scholar 

  20. Bromander AK, Ekman L, Kopf M, Nedrud JG, Lycke NY: IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol 1996; 156:4290–4297.

    PubMed  CAS  Google Scholar 

  21. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M: The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561–563.

    Article  PubMed  CAS  Google Scholar 

  22. Selsted ME, Szklarek D, Lehrer RI: Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun 1984;45:150–154.

    PubMed  CAS  Google Scholar 

  23. Fleischmann J, Church JA, Lehrer RI. Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 1986;291: 334–341.

    Article  PubMed  CAS  Google Scholar 

  24. Porter EM, VanDam E, Valore EV, Ganz T: Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun 1997;65:2396–2401.

    PubMed  CAS  Google Scholar 

  25. Porter EM, Liu L, Oren A, Anton PA, Ganz T: Localization of human intestinal defensin 5 in paneth cell granules. Infect Immun 1997; 65:2389–2395.

    PubMed  CAS  Google Scholar 

  26. Harwig SS, Park AS, Lehrer RI: Characterization of defensin precursors in mature human neutrophils. Blood 1992;79:1532–1537.

    PubMed  CAS  Google Scholar 

  27. Jones DE, Bevins CL: Paneth cells of the human small intestine express in antimicrobialmpeptide gene. J Bio Chem 1992;267: 23216–23225.

    CAS  Google Scholar 

  28. Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M: Epithelial antibiotic induced in states of diseased. Proc Natl Acad Sci (USA) 1997;94:8686–8690.

    Article  CAS  Google Scholar 

  29. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW: Defensive are mitogenic for epithelial cells and fibroblasts. J CellPhysiol 1993;155: 408–113.

    CAS  Google Scholar 

  30. Eisenhauer PB, Harwig SS, Lehrer RI. Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 1992;60:3556–3565.

    PubMed  CAS  Google Scholar 

  31. Huttner KM, Selsted ME, Ouellette AJ: Structure and diversity of the murine cryptdin gene family. Genomics 1994;19:448–453.

    Article  PubMed  CAS  Google Scholar 

  32. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Bio Chem 1996;271: 2935–2940.

    Article  CAS  Google Scholar 

  33. Boismenu R, Feng L, Xia YY, Chang JC, Harvan WL: Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol 1996; 157:985–992.

    PubMed  CAS  Google Scholar 

  34. Keiner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: a cytokine that represents a new class of chemokine. Science 1994;266:1395–1399.

    Article  Google Scholar 

  35. Kennedy J, Keiner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssl H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphoactin. J Immunol 1995;155:203–209.

    PubMed  CAS  Google Scholar 

  36. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D’Amico G, Power CA, Wells TN, Gobbi M, Allavena P, Mantovani A: Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997;159:1993–2000.

    PubMed  CAS  Google Scholar 

  37. Giancarlo B, Silvano S, Albert Z, Mantovani A, Allavena P: Migratory response of human natural killer cells to lymphotactin. Eur J Immunol 1996;26:3238–3241.

    Article  PubMed  CAS  Google Scholar 

  38. Borthwick NJ, Akbar AN, MacCormac LP, Lowdell M, Craigen JL, Hassan I, Grundy JE, Salmon M, Yong KL: Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration. Immunol 1997;90:272–280.

    Article  CAS  Google Scholar 

  39. McGhee JR, Lamm ME, Strober W: Mucosal immune responses: An overview: in Orga PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. Academic press, 1999, pp 485–506.

  40. Rollwagen FM, Baqar S: Oral cytokine administration. Immunol Today 1996;17:548–550.

    Article  PubMed  CAS  Google Scholar 

  41. Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR: Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 1997;185:415–4127.

    Article  PubMed  CAS  Google Scholar 

  42. Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR: Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 1999; 162:114–121.

    PubMed  CAS  Google Scholar 

  43. Boyaka PN, Marinaro M, Jackson RJ, Menon S, Kiyono H, Jirillo E, McGhee JR: IL-12 is an effective adjuvant for induction of mucosal immunity. J Immunol 1999; 162:122–128.

    PubMed  CAS  Google Scholar 

  44. Elson CO, Dertzbaugh MT: 1999. Mucosal adjuvants, in Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds): Mucosal Immunology. Academic press, 1999, pp 817–838.

  45. Baqar S, Pacheco ND, Rollwagen FM: Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother 1993; 37:2688–2692.

    PubMed  CAS  Google Scholar 

  46. Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K: Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 1997;159: 3638–36547.

    PubMed  CAS  Google Scholar 

  47. Arulanandam BP, Metzger DW: Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. Vaccine 1999; 17:252–260.

    Article  PubMed  CAS  Google Scholar 

  48. Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR: Mechanisms for mucosal immunogenicity and adjuvancy ofEscherichia coli labile enterotoxin. J Infect Dis 1996;173: 627–635.

    PubMed  CAS  Google Scholar 

  49. Levine MM, Kaper JB, Black RE, Clements ML: New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiological Reviews 1983;47:510–550.

    PubMed  CAS  Google Scholar 

  50. Douce G, Turcotte C, Cropley I, Roberts M, Pizza M, Domenghini M, Rappuoli R, Dougan G: Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci (USA) 1995;92:1644–1648.

    Article  CAS  Google Scholar 

  51. Yamamoto S, Kiyono H, Yamamoto M, Imaoka F, Fujihashi K, VanGinkel FW, Noda M, Takeda Y, McGhee JR: A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci (USA) 1997;94:5267–5272.

    Article  CAS  Google Scholar 

  52. Germann T, Guckes S, Bongartz M, Dlugonska H, Schmitt E, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E: Adminstration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Intern Immunol 1995;7:1649–1657.

    Article  CAS  Google Scholar 

  53. Wynn TA, Jankovic D, Hieny S, Zioncheck K, Jardieu P, Cheever AW, Sher A: IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J Immunol 1995;154:3999–4009.

    PubMed  CAS  Google Scholar 

  54. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI: Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985;76: 1427–1435.

    Article  PubMed  CAS  Google Scholar 

  55. Ogata K, Linzer BA, Zuberi RI, Ganz T, Lehrer RI, Catanzaro A: Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun 1992;60:4720–4725.

    PubMed  CAS  Google Scholar 

  56. Lillard Jr. WJ, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR: Mechanism for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci (USA) 1999;96:651–656.

    Article  CAS  Google Scholar 

  57. Fujihashi K, Yamamoto M, McGhee JR, Beagley KW, Kiyono H: Function of alpha beta TCR+ intestinal intraepithelial lymphocytes: Th1-and Th2-type cytokine production by CD4+CD8- and CD4+CD8- T cells for helper activity. Intern Immunol 1993;5:1473–1481.

    Article  CAS  Google Scholar 

  58. Kawabata S, Boyaka PN, Coste M, Fujihashi K, Yamamoto M, McGhee JR, Kiyono H: Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics. Gastroenterology 1998;115:866–873.

    Article  PubMed  CAS  Google Scholar 

  59. Barrett TA, Gajewski TF, Danielpour D, Chang EB, Beagley KW, Bluestone JA: Differential function of intestinal intraepithelial lymphocyte subsets. J Immunol 1992;149:1124–1130.

    PubMed  CAS  Google Scholar 

  60. Taguchi T, Aicher WK, Fujihashi K, Yamamoto M, McGhee JR, Bluestone JA, Kiyono H: Novel function for intestinal intraepithelial lymphocytes. Murine CD3+ gamma/delta TCR+ T cells produce IFN-gamma and IL-5. J Immunol 1991;147:3736–3744.

    PubMed  CAS  Google Scholar 

  61. Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel T, Zlotnik A: Lymphotactin is produced by NK cells and attracts both NK cells and T cellsin vivo. J Immunol 1997;158:1533–1540.

    PubMed  CAS  Google Scholar 

  62. Dilloo D, Bacon K Holden W, Zhong W, Burdach S, Zlotnik A, Brenner M: Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nature Med 1996;2:1090–1095.

    Article  PubMed  CAS  Google Scholar 

  63. Lillard Jr. JW, Boyaka PN, Hedrick JA, Zlotnik A, McGhee JR: Lymphotactin acts as an innate mucosal adjuvant. J Immunol 1999; 162:1959–1965.

    PubMed  CAS  Google Scholar 

  64. Fujihashi K, McGhee JR, Kweon MN, Cooper MD, Tonegawa S, Takahashi I, Hiroi T, Mestecky J, Kiyono H: Gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996;183: 1929–1935.

    Article  PubMed  CAS  Google Scholar 

  65. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombaerts P, Tonegawa S, Yamamoto H, Itohara S, Nanno M, Ishikawa H: Homeostatic regulation of intestinal epithelial by intraepithelial gamma delta T cells. Proc Natl Acad Sci (USA) 1995;92:6147–6151.

    Article  CAS  Google Scholar 

  66. vanGinkel FW, McGhee JR, Liu C, Simecka JW, Yamamoto M, Frizzell RA, Sorscher EJ, Kiyono H, Pascual DW: Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J Immunol 1997;159: 685–693.

    CAS  Google Scholar 

  67. Cong Y, Weaver CT, Elson CO: The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective, up-regulation of B7.2 expression. J Immunol 1997; 159: 5301–5308.

    PubMed  CAS  Google Scholar 

  68. Van Cott JL, Chatfield SN, Roberts M, Hone DM, Hohmann EL, Pascual DW, Yamamoto M, Kiyono H, McGhee JR: Regulation of host immune responses by modification of Salmonella virulence genes. Nature Med 1998;4:1247–1252.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Immunobiology Vaccine Center, The University of Alabama at Birmingham, 761 BBRB, 845 19th Street South, 35294-2170, Birmingham, Alabama

    Prosper N. Boyaka, James W. Lillard &  Jerry McGhee

  2. Department of Microbiology and Immunology, Morehouse School of Medicine, Atlanta, GA

    James W. Lillard

Authors
  1. Prosper N. Boyaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James W. Lillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jerry McGhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boyaka, P.N., Lillard, J.W. & McGhee, J. Interleukin 12 and innate molecules for enhanced mucosal immunity. Immunol Res 20, 207–217 (1999). https://doi.org/10.1007/BF02790404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02790404

Key Words

Search

Navigation